-
1مورد إلكتروني
مصطلحات الفهرس: plaque psoriasis, obesity, diet, awareness, info:eu-repo/semantics/article
URL:
https://hdl.handle.net/10281/446799Test
info:eu-repo/semantics/altIdentifier/pmid/37909326
info:eu-repo/semantics/altIdentifier/wos/WOS:001103902500001
journal:JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY -
2مورد إلكتروني
-
3مورد إلكتروني
مصطلحات الفهرس: Apremilast, Dermatology Life Quality Index, Italian real-world evidence, Patient Benefit Index, Patient perspective, Patient-reported outcomes, Plaque psoriasis, Psoriasis comorbidities, Quality of life, Treatment satisfaction, Settore MED/35 - MALATTIE CUTANEE E VENEREE, info:eu-repo/semantics/article
URL:
https://hdl.handle.net/10807/249100Test
info:eu-repo/semantics/altIdentifier/wos/WOS:000986364300001
volume:40
issue:7
firstpage:3021
lastpage:3037
numberofpages:17
issueyear:2023
journal:ADVANCES IN THERAPY -
4مورد إلكتروني
المصدر: Kirkham , B W , Egeberg , A , Behrens , F , Pinter , A , Merola , J F , Holzkämper , T , Gallo , G , Ng , K J , Bolce , R , Schuster , C , Nash , P & Puig , L 2023 , ' A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis ' , Rheumatology and Therapy , vol. 10 , no. 5 , pp. 1127-1146 .
مصطلحات الفهرس: Ixekizumab, Nail psoriasis, Plaque psoriasis, Psoriatic arthritis, article
URL:
https://curis.ku.dk/portal/da/publications/a-comprehensive-review-of-ixekizumab-efficacy-in-nailTest-psoriasis-from-clinical-trials-for-moderatetosevere-psoriasis-and-psoriatic-arthritis(482994f9-5baf-41ad-8542-2663959587cf).html https://doi.org/10.1007/s40744-023-00553-1Test https://curis.ku.dk/ws/files/366044430/s40744_023_00553_1.pdfTest -
5مورد إلكتروني
مصطلحات الفهرس: Biologics, IL-12/23 inhibitors, IL-17 inhibitors, JAK inhibitors, clinical trial, monoclonal antibodies, plaque psoriasis, small molecules, systemic treatments, Settore MED/35 - MALATTIE CUTANEE E VENEREE, info:eu-repo/semantics/article
URL:
https://hdl.handle.net/10807/229025Test
info:eu-repo/semantics/altIdentifier/pmid/36852779
issue:N/A
firstpage:1
lastpage:15
numberofpages:15
issueyear:2023
journal:EXPERT OPINION ON INVESTIGATIONAL DRUGS -
6مورد إلكتروني
مصطلحات الفهرس: absolute PASI, brodalumab, health-related quality of life, itching, plaque psoriasis, real-life patients, Journal Article, VoR
-
7مورد إلكتروني
مصطلحات الفهرس: absolute PASI, brodalumab, health-related quality of life, itching, plaque psoriasis, real-life patients, Journal Article, VoR
-
8مورد إلكتروني
مصطلحات الفهرس: Adolescents, Biologics, Children, Corticosteroid-sparing, Health-related quality of life, Pediatric psoriasis, Plaque psoriasis, Systemic therapy, Topical corticosteroids, Settore MED/35 - MALATTIE CUTANEE E VENEREE, info:eu-repo/semantics/article
URL:
https://hdl.handle.net/10807/229046Test
info:eu-repo/semantics/altIdentifier/wos/WOS:000820478000001
volume:12
issue:8
firstpage:1753
lastpage:1775
numberofpages:23
issueyear:2022
journal:DERMATOLOGY AND THERAPY -
9مورد إلكتروني
المصدر: Yao , Y , Jorgensen , A-H R , Nielsen , V W , Egeberg , A , Thyssen , J P & Thomsen , S F 2022 , ' Sonelokimab Interleukin-17A and -F nanobody Treatment of moderate to severe psoriasis Treatment of hidradenitis suppurativa ' , Drugs of the Future , vol. 47 , no. 8 , pp. 567-573 .
مصطلحات الفهرس: IL-17, Monoclonal antibody, Nanobody, Psoriasis, Sonelokimab, M-1095, SEVERE PLAQUE PSORIASIS, DOUBLE-BLIND, MULTICENTER, EFFICACY, SAFETY, BIMEKIZUMAB, MECHANISMS, FAMILY, SHARK, article
URL:
https://curis.ku.dk/portal/da/publications/sonelokimab-interleukin17a-and-f-nanobody-treatment-of-moderate-to-severeTest-psoriasis-treatment-of-hidradenitis-suppurativa(ba60ffe8-f84c-4650-838d-2a8ab5c6a38a).html https://doi.org/10.1358/dof.2022.47.8.3435135Test -
10مورد إلكتروني
مصطلحات الفهرس: Guselkumab, efficacy, plaque psoriasis, real-world, treatment, Settore MED/35 - MALATTIE CUTANEE E VENEREE, info:eu-repo/semantics/article
URL:
http://hdl.handle.net/10807/214086Test
info:eu-repo/semantics/altIdentifier/pmid/35708257
info:eu-repo/semantics/altIdentifier/wos/WOS:000815390400001
issue:N/A
firstpage:1
lastpage:8
numberofpages:8
issueyear:2022
journal:EXPERT OPINION ON BIOLOGICAL THERAPY